SIS
HRMY icon

Strategic Investment Solutions’s Harmony Biosciences HRMY Stock Holding History

Strategic Investment Solutions’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64K Hold
100
– – ﹤0.01% 537
2026
Q1 		$2.8K Hold
100
– – ﹤0.01% 542
2025
Q4 		$3.74K Hold
100
– – ﹤0.01% 498
2025
Q3 		$2.76K Hold
100
– – ﹤0.01% 498
2025
Q2 		$3.16K Hold
100
– – ﹤0.01% 470
2025
Q1 		$3.32K Buy
+100
New +$3.58K ﹤0.01% 484

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strategic Investment Solutions's HRMY Position: Q2 2026 in Review

Strategic Investment Solutions held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 100 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Strategic Investment Solutions first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.74K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Strategic Investment Solutions held 100 shares of Harmony Biosciences worth $3.64K as of Q2 2026.
  • Strategic Investment Solutions left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #537 holding.
  • Strategic Investment Solutions first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Strategic Investment Solutions's Harmony Biosciences position peaked at $3.74K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.